Fonte: Veterinary and Comparative Oncology. Unidades: FMVZ, FZEA
Assuntos: CÃES (PATOLOGIA), MASTOCITOMA ANIMAL, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PULZ, Lidia Hildebrand et al. Increased expression of tissue inhibitor of metalloproteinase-1 correlates with improved outcome in canine cutaneous mast cell tumours. Veterinary and Comparative Oncology, v. 15, n. 2, p. 606-614, 2017Tradução . . Disponível em: https://doi.org/10.1111/vco.12204. Acesso em: 22 ago. 2024.APA
Pulz, L. H., Barra, C. N., Kleeb, S. R., Xavier, J. G., Catão-Dias, J. L., Sobral, R. A., et al. (2017). Increased expression of tissue inhibitor of metalloproteinase-1 correlates with improved outcome in canine cutaneous mast cell tumours. Veterinary and Comparative Oncology, 15( 2), 606-614. doi:10.1111/vco.12204NLM
Pulz LH, Barra CN, Kleeb SR, Xavier JG, Catão-Dias JL, Sobral RA, Fukumasu H, Strefezzi R de F. Increased expression of tissue inhibitor of metalloproteinase-1 correlates with improved outcome in canine cutaneous mast cell tumours [Internet]. Veterinary and Comparative Oncology. 2017 ; 15( 2): 606-614.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1111/vco.12204Vancouver
Pulz LH, Barra CN, Kleeb SR, Xavier JG, Catão-Dias JL, Sobral RA, Fukumasu H, Strefezzi R de F. Increased expression of tissue inhibitor of metalloproteinase-1 correlates with improved outcome in canine cutaneous mast cell tumours [Internet]. Veterinary and Comparative Oncology. 2017 ; 15( 2): 606-614.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1111/vco.12204
